Conditions : Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Pain; Arthralgia; Joint Pain Interventions : Drug: JNJ-42160443; Drug: JNJ-42160443; Drug: JNJ-42160443; Drug: Placebo; Drug: JN...

Conditions : Musculoskeletal Diseases; Rheumatoid Arthritis Intervention : Behavioral: Patient-centered group intervention Sponsor : Sint Maartenskliniek Active, not recruiting - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Biological: LY2439821; Drug: Placebo Sponsor : Eli Lilly and Company Active, not recruiting - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Biological: LY2439821; Drug: Placebo Sponsor : Eli Lilly and Company Active, not recruiting - verified August 2011

Condition : Non-inflammatory Degenerative Joint Disease Intervention : Procedure: Total Hip Replacement Sponsors : Anderson Orthopaedic Research Institute; University of Western Ontario, Canada; DePuy...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: folic acid Sponsors : Hoffmann-La Roche; Hoffma...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: placebo; Drug: tocilizumab [RoActemra/Actemra] Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed -...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: placebo; Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Active, not recruiting - verifi...

This study will evaluate the effect of etanercept on the clinical benefit, safety, and physical functioning (ability to function in daily life) in children and adolescent subjects with 3 subtypes of c...

This study will evaluate the effect of etanercept on the clinical benefit, safety, and physical functioning (ability to function in daily life) in children and adolescent subjects with 3 subtypes of c...